• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在癫痫监测病房口服负荷量拉莫三嗪的耐受性和药代动力学

Tolerability and pharmacokinetics of oral loading with lamotrigine in epilepsy monitoring units.

作者信息

Lardizabal David V, Morris Harold H, Hovinga Collin A, Del Mar Carreño Maria

机构信息

Department of Neurology, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

出版信息

Epilepsia. 2003 Apr;44(4):536-9. doi: 10.1046/j.1528-1157.2003.46902.x.

DOI:10.1046/j.1528-1157.2003.46902.x
PMID:12681002
Abstract

PURPOSE

To investigate the tolerability and pharmacokinetics of oral loading with lamotrigine (LTG) among epilepsy patients after temporary drug discontinuation in an epilepsy monitoring unit.

METHODS

We conducted a pilot study among epilepsy patients (18 years or older) receiving maintenance doses of LTG. LTG was discontinued on admission and restarted at the end of epilepsy monitoring. LTG was given as a single oral dose calculated based on the population expected volume of distribution (Vd, 1.0 L/kg) and target blood level on admission. Baseline and serial blood levels of LTG were determined hourly for 10 to 12 h after the loading dose.

OUTCOME MEASURES

(a) frequency of patients with side effects; (b) time to maximum concentration (Tmax), maximum concentration (Cmax), actual volume of distribution, and half-life.

RESULTS

Twenty-four patients received a single oral load of LTG (mean, 6.5 +/- 2.7 mg/kg). Overall, LTG loading was well tolerated with no serious adverse events or skin rash observed. Two patients had transient and mild nausea 1 to 2 h after the oral load. The mean estimated pharmacokinetic parameters are as follows: Tmax, 3.1 +/- 2.1 h; Cmax, 8.2 +/- 6.5 mg/L; Vd, 1.1 +/- 1.0 L/kg; clearance, 0.08 +/- 0.08 mg/L/h; half-life, 22 +/- 30 h. All patients reached their target blood levels.

CONCLUSIONS

Epilepsy patients temporarily discontinued from LTG can be restarted with a single oral loading dose. This was well tolerated, and therapeutic levels can be achieved within 1 to 3 h.

摘要

目的

在癫痫监测单元中,研究癫痫患者临时停药后口服负荷剂量拉莫三嗪(LTG)的耐受性和药代动力学。

方法

我们对接受LTG维持剂量治疗的癫痫患者(18岁及以上)进行了一项试点研究。患者入院时停用LTG,在癫痫监测结束时重新开始用药。根据人群预期分布容积(Vd,1.0 L/kg)和入院时的目标血药浓度计算,给予患者单次口服LTG负荷剂量。负荷剂量给药后10至12小时内,每小时测定LTG的基线血药浓度和系列血药浓度。

观察指标

(a)出现副作用的患者频率;(b)达峰时间(Tmax)、最大浓度(Cmax)、实际分布容积和半衰期。

结果

24例患者接受了单次口服LTG负荷剂量(平均剂量为6.5±2.7 mg/kg)。总体而言,LTG负荷剂量耐受性良好,未观察到严重不良事件或皮疹。两名患者在口服负荷剂量后1至2小时出现短暂轻度恶心。平均估计药代动力学参数如下:Tmax为3.1±2.1小时;Cmax为8.2±6.5 mg/L;Vd为1.1±1.0 L/kg;清除率为0.08±0.08 mg/L/h;半衰期为22±30小时。所有患者均达到目标血药浓度。

结论

临时停用LTG的癫痫患者可单次口服负荷剂量重新开始用药。该方法耐受性良好,可在1至3小时内达到治疗血药浓度。

相似文献

1
Tolerability and pharmacokinetics of oral loading with lamotrigine in epilepsy monitoring units.在癫痫监测病房口服负荷量拉莫三嗪的耐受性和药代动力学
Epilepsia. 2003 Apr;44(4):536-9. doi: 10.1046/j.1528-1157.2003.46902.x.
2
Topiramate and lamotrigine pharmacokinetics during repetitive monotherapy and combination therapy in epilepsy patients.癫痫患者重复单一疗法和联合疗法期间托吡酯和拉莫三嗪的药代动力学
Epilepsia. 2003 Jul;44(7):917-22. doi: 10.1046/j.1528-1157.2003.64402.x.
3
Lamotrigine high-dose tolerability and safety in patients with epilepsy: a double-blind, placebo-controlled, eleven-week study.拉莫三嗪在癫痫患者中的高剂量耐受性和安全性:一项双盲、安慰剂对照的十一周研究。
Epilepsia. 1996 Sep;37(9):857-62. doi: 10.1111/j.1528-1157.1996.tb00038.x.
4
Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (The COMPASS Study).在癫痫患者中从每日两次速释制剂转换为每日一次缓释制剂时拉莫三嗪的稳态药代动力学(COMPASS研究)
Epilepsia. 2008 Mar;49(3):410-7. doi: 10.1111/j.1528-1167.2007.01274.x. Epub 2007 Sep 6.
5
Rectal absorption of lamotrigine compressed tablets.拉莫三嗪压制片的直肠吸收
Epilepsia. 2000 Jul;41(7):850-3. doi: 10.1111/j.1528-1157.2000.tb00252.x.
6
Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy.癫痫患者中拉莫三嗪血清浓度与耐受性的相关性
Neurology. 2004 Sep 28;63(6):1022-6. doi: 10.1212/01.wnl.0000138424.33979.0c.
7
Effect of oral contraceptives on lamotrigine levels depends on comedication.口服避孕药对拉莫三嗪水平的影响取决于合并用药。
Acta Neurol Scand. 2014 Jun;129(6):393-8. doi: 10.1111/ane.12197. Epub 2013 Nov 8.
8
Lamotrigine.拉莫三嗪
Epilepsia. 1995;36 Suppl 2:S87-94. doi: 10.1111/j.1528-1157.1995.tb06002.x.
9
Safety of an intravenous formulation of lamotrigine.拉莫三嗪静脉制剂的安全性。
Seizure. 2014 May;23(5):390-2. doi: 10.1016/j.seizure.2014.01.019. Epub 2014 Jan 31.
10
Effect of comedication on lamotrigine clearance in Korean epilepsy patients.合并用药对韩国癫痫患者拉莫三嗪清除率的影响。
Clin Chim Acta. 2015 Jan 1;438:269-73. doi: 10.1016/j.cca.2014.09.004. Epub 2014 Sep 8.

引用本文的文献

1
Pre- and Post-Exposure Prophylaxis for HIV in Patients Taking Anti-Seizure Medications.服用抗癫痫药物患者的HIV暴露前和暴露后预防
Epilepsy Curr. 2024 May 28;24(4):219-231. doi: 10.1177/15357597241253500. eCollection 2024 Jul-Aug.
2
Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials.年龄相关因素对拉莫三嗪药代动力学的影响及其对未来临床试验维持剂量优化的潜在意义。
Clin Pharmacokinet. 2018 Aug;57(8):1039-1053. doi: 10.1007/s40262-017-0614-5.
3
Variation in dose and plasma level of lamotrigine in patients discharged from a mental health trust.
一家精神卫生信托机构出院患者中拉莫三嗪的剂量和血浆水平差异。
Ther Adv Psychopharmacol. 2017 Jan;7(1):17-24. doi: 10.1177/2045125316672573. Epub 2016 Oct 13.
4
Investigation of connexin 43 uncoupling and prolongation of the cardiac QRS complex in preclinical and marketed drugs.临床前和上市药物中连接蛋白43解偶联与心脏QRS波群延长的研究
Br J Pharmacol. 2014 Nov;171(21):4808-19. doi: 10.1111/bph.12554. Epub 2014 Aug 13.
5
Lamotrigine pharmacokinetic evaluation in epileptic patients submitted to VEEG monitoring.接受视频脑电图监测的癫痫患者中拉莫三嗪的药代动力学评估。
Eur J Clin Pharmacol. 2006 Sep;62(9):737-42. doi: 10.1007/s00228-006-0144-9. Epub 2006 Jul 27.